Tsung‐Hui Hu

Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

Philip J. Johnson, Shukui Qin, Joong‐Won Park et al. · Journal of Clinical Oncology · 2013 · 775 citations · Full text

Medicine, Oncology, Pharmacology +14

Hepatogastroenterology

Lung‐Sheng Lu, Fu‐Chih Hung, Seng‐Kee Chuah et al. · Hepatogastroenterology · 2012 · 536 citations

Medicine, Molecular Biology, Oncology +17

Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients

Chien‐Hung Chen, Chao‐Hung Hung, Chuan–Mo Lee et al. · Gastroenterology · 2007 · 232 citations

Medicine, Genetics, Molecular Genetics +13

Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients

Tung‐Hung Su, Tsung‐Hui Hu, Chi‐Yi Chen et al. · Liver International · 2016 · 221 citations

Pharmacy, Oncology, Pharmacotherapy +17

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients

Sung‐Nan Pei, Chien‐Hung Chen, Chuan–Mo Lee et al. · Annals of Hematology · 2009 · 211 citations

Life Sciences, Immunology, Infectious Diseases +17